Down-regulation of Interleukin-6 and its receptor (F11) results in growth inhibition of MCF-7 breast cancer cells[50], while high affinity of Insulin receptor binding (F7) has been observed in the same cells[51]. The gene discussed is IL6; the disease is breast carcinoma.